The Musashi RNA-binding proteins in female cancers: insights on molecular mechanisms and therapeutic relevance

Mark Sicking1, Isabel Falke1, Maria T Löblein1

  • 1Department of Radiation Oncology, University Hospital Münster, Albert Schweitzer-Campus 1, 48149, Münster, Germany.

Biomarker Research
|August 24, 2023
PubMed

Insights

Musashi proteins regulate gene expression and are implicated in various cancers, particularly female malignancies. Further research is ongoing to understand their role in cancer stem cells and develop targeted therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • RNA-binding proteins regulate gene expression and are implicated in cancer development.
  • Musashi-1 and Musashi-2, initially developmental factors, are now recognized in various physiological tissues and pathological cell behaviors.
  • Dysregulation of Musashi proteins is observed in multiple cancer types, including female malignancies.

Purpose of the Study:

  • To review the role of Musashi proteins in female reproductive cancers.
  • To summarize current knowledge on Musashi proteins in breast, endometrial, ovarian, and cervical cancers.
  • To discuss future perspectives on targeting Musashi proteins in cancer therapy.

Main Methods:

  • Literature review focusing on Musashi proteins in female cancers.
  • Analysis of current research on Musashi protein function in tumorigenesis.
  • Synthesis of data on Musashi proteins as cancer stem cell markers.

Main Results:

  • Musashi proteins are implicated in cancer stem cell characteristics, including proliferation and therapy resistance.
  • Evidence suggests Musashi proteins play a role in the progression of breast, endometrial, ovarian, and cervical cancers.
  • The exact mechanisms and signaling pathways involving Musashi proteins in cancer require further elucidation.

Conclusions:

  • Musashi proteins are significant regulators in female cancers, acting as potential cancer stem cell markers.
  • Targeting Musashi proteins presents a promising therapeutic strategy for various malignancies.
  • Continued research is crucial to fully understand and exploit the therapeutic potential of Musashi proteins.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.2K